长期幸存者患有神经瘤大脑缩症和小细胞肺癌
Konstantinos Tsoukalas1, Ioannis Ntanasis-Stathopoulos1, Angeliki Andrikopoulou1
1Department of Clinical Therapeutics, Alexandra General Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece.
Journal of clinical medicine
|January 25, 2025
概括
与小细胞肺癌 (SCLC) 相关的瘤大脑退化症 (PCD) 的早期检测和化疗可以带来显著的生存益处和缓解. 及时治疗为这种罕见的神经疾病提供了充满希望的预后.
科学领域:
- 神经学 神经学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 副新生性小脑退化症 (PCD) 是一种针对普金尼细胞的自身免疫性疾病,通常与小细胞肺癌 (SCLC) 相关.
- 由于渐进的小脑功能障碍和神经损伤,PCD通常呈现出不良的预后.
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...